Table 3.
PASS thresholds with 95% confidence interval estimated using weighted predictive modelling with hip-specific patient satisfaction as anchor for FJS and OHS, and EQ-VAS as anchor for the EQ-5D-5L
| 3 months data | 12 months data | |||||
|---|---|---|---|---|---|---|
| r | PASS | SNS/SPS | r | PASS | SNS/SPS | |
| FJS | 0.35 | 31.5 (29.5–33.9) | 0.79/0.82 | 0.46 | 38.3 (36.5–42.4) | 0.82/0.85 |
| OHS | 0.41 | 31.5 (29.1–32.8) | 0.81/0.84 | 0.54 | 36.2 (35.1–36.8) | 0.90/0.99 |
| EQ-5D-5 L | 0.47 | 0.814 (0.795–0.822) | 0.80/0.68 | 0.52 | 0.867 (0.845–0.875) | 0.80/0.72 |
| FJS, forgotten joint score; OHS, oxford hip score; EQ-5D-5L, EuroQol five dimension five level health index; EQ-VAS, visual analogue scale of the EuroQol five dimension five level r, spearman rank correlation between dichotomised anchor and PROM, SNS, sensitivity; SPS, specificity | ||||||